Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001404644-25-000081
Filing Date
2025-08-11
Accepted
2025-08-11 16:05:41
Documents
78
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ngne-20250630.htm   iXBRL 10-Q 1504070
2 EX-1.1 ngne_2025atm-salesagreemen.htm EX-1.1 314120
3 EX-5.1 exhibit51opinion.htm EX-5.1 7557
4 EX-31.1 ngne-2025formq210xqxex311p.htm EX-31.1 9419
5 EX-31.2 ngne-2025formq210xqxex312p.htm EX-31.2 9550
6 EX-32.1 ngne-2025formq210xqxex321.htm EX-32.1 7163
12 image_1a.jpg GRAPHIC 26135
13 ngne-20250630_g1.jpg GRAPHIC 83706
14 ngne-20250630_g2.jpg GRAPHIC 93681
  Complete submission text file 0001404644-25-000081.txt   7771295

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20250630.xsd EX-101.SCH 45879
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngne-20250630_cal.xml EX-101.CAL 55266
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngne-20250630_def.xml EX-101.DEF 206018
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20250630_lab.xml EX-101.LAB 612167
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20250630_pre.xml EX-101.PRE 420372
81 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20250630_htm.xml XML 873198
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 251201984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)